Pelthos Therapeutics Inc.
PTHS
$26.90
$0.602.28%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -600.88% | -444.56% | -134.22% | 7.73% | 18.00% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 99.45% | -62.60% | -37.50% | -53.65% | -76.33% |
| Total Other Non-Cash Items | 1,218.09% | 1,583.88% | 52.74% | -62.17% | -61.03% |
| Change in Net Operating Assets | -927.88% | -17,444.29% | -1,595.07% | 845.95% | -9.34% |
| Cash from Operations | -691.58% | -290.02% | -210.43% | 65.33% | -58.32% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 5,965.90% | 3,368.47% | -37.69% | -121.75% | 31.00% |
| Total Debt Repaid | -1,329,400.00% | -293.02% | -293.02% | 99.91% | 99.91% |
| Issuance of Common Stock | 148.19% | -96.60% | -97.30% | -98.67% | -98.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 144.58% | 99.45% | 99.45% |
| Cash from Financing | 9,052.78% | 630.17% | 305.95% | -105.32% | -87.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 982.03% | 4,099.09% | 954.54% | -200.97% | -197.78% |